For the 2017 drug market trend, more business to worry about, because the majority of medicine prices in 2016 has risen, farmers get a better income, drug boom again in the origin of the drug in full swing. In fact, in accordance with the drug market cycle, the fourth round of the price cycle should arrive in 2018.
2016, the majority of herbs prices rose in advance, whether it indicates that this round of price cycle halfway die.
Product | Rise in price circumstance |
Radix notoginseng | Rise to above 800 yuan |
Platycodon grandiflorum | Rise to about 85 yuan |
Codonopsis pilosula | break through 100 yuan |
Angelica sinensis | Rise to about 60 yuan |
Szechuan Lovage Rhizome | Rise to 34-35 yuan |
Rhizoma Atractylodis | break through 40 yuan |
Indigowoad Root | From 5-6 yuan sharply rise to 30 yuan |
Rhizoma corydalis | Rise to above 80 yuan |
Radix pseudostellariae | Rise to 370 - 380 yuan |
burdock | Rise to about 38yuan |
Radix Ophiopogonis | In the first half of the year, the price of Ophiopogon japonica is still 20 yuan (Sichuan) from top to bottom, to April 2011 has soared to about 140 yuan, creating a high price ever |
Coptis chinensis | Early in 1998 the price is still hovering around 26 yuan, in March 2000 the price has risen to 110 yuan or more, to September prices have exceeded 220 yuan high prices |
Looking at the 2016 price increases, there is no third round of the cycle, the majority of herbs prices did not rise to the last round of the cycle price, such as: Atractylodes, the third round of the cycle price rose to 40 yuan or more, the price rose to 28 yuan or so; Angelica price in the last round of the general cargo prices rose to 16-17 yuan, while the time the goods prices rose to only 9 yuan; there are scutellaria, wind, North Sha Senate, Campanulaceae, Scrophulariaceae, Chuanxiong, Ze Diarrhea, sea gold sand, turmeric, burdock, white before, Aster, chrysanthemum, honeysuckle, etc., more than the price of herbs did not catch the wheel market.
In fact, the majority of 2016 drug prices if you continue to hover in the valley for a year, the market outlook will be pregnant with greater business opportunities!
Such as Atractylodes, if Atractylodes 12 yuan from top to bottom continued to run until the end of 2016, not only dampen the enthusiasm of drug growers, and breeding base will appear serious lack of seedling phenomenon, when you want to plant can not buy more seedlings, then the city has How much room for price increases is hard to imagine. There are Campanulaceae, if not one year ahead of price increases, one hundred yuan high price really is not a dream Does this mean that the drug market in 2017 is harder and again, according to the first three rounds of price increases inferred, price increases for at least 2-3 years. If the 2017 drug market is really calm, the majority of drug providers do not have to pessimistic, the future drug market will lurking a greater business opportunities. Things are constantly changing in the development, the drug market in 2017 there are still many uncertainties.
1, The national policy to vigorously support Chinese medicine, the future prospects of drug market is more bright.
2016 a series of policies to bring good medicine to the Chinese medicine brought the spring, the first Chinese medicine into the {{People's Republic of China national economy and development of the thirteenth five-year plan}}, the State Council issued a {{Chinese medicine development strategy Outline (2016-2030)}}, to achieve the basic enjoyment of all Chinese medicine medicine services in 2020, and the Chinese medicine Pieces into the scope of medical insurance reimbursement.
So, the demand for raw materials will be increasing year by year trend, excess Chinese herbal medicine raw materials will be effectively digested. Demand is the last word, as long as the demand for medicine prices will not fall sharply. Policy on the good, will support the price of medicine is difficult to substantially decline, and even some medicinal herbs in the market demand increased driven by the rise.
2, High quality authentic medicine prices are expected to rise further
2015 new {{Pharmacopoeia}} after the promulgation of the implementation of the drug unit pay more attention to the quality of herbs, heavy metals, pesticides, sulfur exceeded the standard of herbs will be shut out, and to {{pharmacopoeia}} standard herbs will be favored by the drug unit , The price naturally higher than the unqualified herbs,
Such as: the current sulfur-free Fritillaria price of 85 yuan, and sulfur prices sold for 80 yuan; sulfur-free chrysanthemum price 36-37 yuan, and sulfur goods sold only 20 yuan; there are sulfur-free peony and sulfur Cargo prices are 2-3 yuan. Effective content more affect the price of herbs, such as: Vitex, Jiangxi genuine content of the standard goods sold around 150 yuan, while the lower imports of goods sold only 12.5 yuan from top to bottom.
The quality of Chinese herbal medicines has affected the price of herbs, the future will have more medicine due to quality prices pulled away from the price, high quality authentic medicine prices are expected to rise further.
3, Medicine and food health care medicine prices continue to improve
The twenty-first century will be a great health industry to obtain great development of the times, more and more people pay attention to health care, and as a medicinal dual-use Chinese herbal medicine raw materials will continue to increase, such as: Codonopsis, Angelica, Chinese wolfberry, cassia seed , Honeysuckle, honeysuckle, ginseng, American ginseng, yam, hawthorn, ebony, jade, lily, coix seed and so on.
With the sales of these medicines continue to increase, its future market is expected to continue to improve, and even some varieties will record high. 2017 years of medicine and medicine will continue to use drugs, do not rule out the emergence of a small number of varieties of prices.
4, Natural disasters is still detonated drug prices fuse
Over the past few years, high temperature, drought, even the rain, floods, the late spring ... ... turn debut, stir up the drug market surging, 2017 drug market will continue to be due to natural disasters, some medicine prices. Flowers and fruits are spring varieties susceptible to the impact of the late spring, and rhizome herbs are susceptible to drought, rainy weather, should pay close attention to different seasons of weather changes, perhaps the business in which.
5, The future drug market is still expected to reproduce the glory
At the beginning of 2016, the Standing Committee of the State Council discussed the adoption of the {{Chinese Medicine Development Strategic Plan (2016-2030)}}. By 2020, the basic necessities of Chinese medicine should be basically enjoyed by Chinese medicine. The total output value of traditional Chinese medicine industry accounted for more than 30% of the total output value of pharmaceutical industry. By 2030, Chinese medicine services to achieve full coverage, the basic form of a hundred by the National Medical Master, 10,000 Chinese medicine teacher, millions of Chinese medicine practitioners, ten million professional skills of Chinese medicine personnel team. The following are the same as the "
The introduction of this policy, for Chinese medicine is undoubtedly a big positive, sales of Chinese herbal medicines will increase with the day, the national policy of strong support, and with the big health, the arrival of a large medical era, New vitality,
Tel: 86-29-88232053
Fax: 86-29-89389576
Email: saledept01@yananchangtai.com
Skype: anthea986
Wechat: 86-13772603194